Regulation of glucose metabolism by incretins: implications for treatment of type 2 diabetes

被引：0
|
作者：
Saito, Rie [1 ]
Harada, Norio [1 ]
机构：
[1] Univ Fukui, Sch Med Sci, Dept Endocrinol & Metab, 23-3 Matsuoka Shimoaizuki,Eiheiji Cho, Fukui 9101193, Japan
来源：
DIABETOLOGY INTERNATIONAL | 2024年
关键词：
Incretin; GIP; GLP-1; Incretin effect; Insulin secretion; GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; NON-ASIANS; SECRETION; TOLERANCE; MELLITUS; EFFICACY; GLP-1; GIP;
D O I：
10.1007/s13340-024-00781-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Gastrointestinal hormones that potentiate insulin secretion from pancreatic beta-cells are called incretins. Glucose-dependent insulinotropic polypeptide/gastric inhibitory polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the major incretins. Incretin-mediated stimulation of insulin secretion (incretin effect) plays an important role in lowering postprandial blood-glucose levels. Incretin effect is reduced under diabetic condition. Several mechanisms have been reported for the reduction of incretin effect. Incretin-related drugs are used worldwide for the treatment of type 2 diabetes. In addition, several new incretin-related drugs have been developed and are expected to be available in clinical practice.
引用
收藏
页数：5
相关论文
共 50 条
  • [31] Caffeine impairs glucose metabolism in type 2 diabetes
    Lane, JD
    Barkauskas, CE
    Surwit, RS
    Feinglos, MN
    DIABETES CARE, 2004, 27 (08) : 2047 - 2048
  • [32] Incretins Role in the Pathophysiology of Type 2 Diabetes Mellitus
    Mythili, S., V
    RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES, 2015, 6 (06): : 698 - 702
  • [33] Effects of Incretins in People with Type 2 Diabetes on CSII
    Chlup, Rudolf
    Zapletalova, Jana
    Cheng, Tzu Hsuan
    Ramik, Zdenek
    Slezakova, Monika
    Zalesakova, Hana
    DIABETES, 2017, 66 : A623 - A623
  • [34] Screening for type 2 diabetes and impaired glucose metabolism
    Colagiuri, S
    Hussain, Z
    Zimmet, P
    Cameron, A
    Shaw, J
    DIABETES CARE, 2004, 27 (02) : 367 - 371
  • [35] Role of leptin in glucose metabolism in type 2 diabetes
    Al-Daghri, N
    Bartlett, WA
    Jones, AF
    Kumar, S
    DIABETES OBESITY & METABOLISM, 2002, 4 (03): : 147 - 155
  • [36] Incretins and cardiovascular disease: to the heart of type 2 diabetes?
    Anna Solini
    Domenico Tricò
    Stefano Del Prato
    Diabetologia, 2023, 66 : 1820 - 1831
  • [37] Incretins and cancer of the bile duct in type 2 diabetes
    Adler, Amanda I.
    BMJ-BRITISH MEDICAL JOURNAL, 2018, 363
  • [38] Incretins, insulin secretion and Type 2 diabetes mellitus
    T. Vilsbøll
    J. J. Holst
    Diabetologia, 2004, 47 : 357 - 366
  • [39] Effects of sustained treatment with lixisenatide on gastric emptying and glucose metabolism in type 2 diabetes
    Rayner, C. K.
    Watson, L. E.
    Phillips, L. K.
    Bound, M. J.
    Grivell, J.
    Wu, T.
    Jones, K. L.
    Horowitz, M.
    Ferrannini, E.
    Trico, D.
    Frascerra, S.
    Mari, A.
    Natali, A.
    DIABETOLOGIA, 2018, 61 : S386 - S387
  • [40] Incretins in type 2 diabetes mellitus: cardiovascular and anti-atherogenic effects beyond glucose lowering
    Psallas, M.
    Manes, C.
    HIPPOKRATIA, 2012, 16 (02) : 100 - 105
12345